Cord Blood America Signs License Agreement to Operate Stem Cell Collection Business in China
Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has signed a License and Cooperation Agreement for the processing and storage of umbilical cord blood in China with AXM Pharma, Inc. .
[Read the full article here]Related News:
Cord Blood America Announces Cord Blood Stem Cell Processing and Storage Agreement With BioCells, a South American …
Cord Blood America Finalizes Cord Blood Stem Cell Processing and Storage Agreement with BioCells, a Major South …
Cord Blood America Contracts With Center for Stem Cell Awareness to Sell Collection and Storage Services in Florida